189 related articles for article (PubMed ID: 33183761)
1. Myeloma cells self-promote migration by regulating TAB1-driven TIMP-1 expression in mesenchymal stem cells.
Rethnam M; Tan DQ; Suda T
Biochem Biophys Res Commun; 2021 Jan; 534():843-848. PubMed ID: 33183761
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of metalloproteinase-2 and -9 (MMP-2, MMP-9), tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1, TIMP-2), and EMMPRIN (CD147) in multiple myeloma.
Urbaniak-Kujda D; Kapelko-Slowik K; Prajs I; Dybko J; Wolowiec D; Biernat M; Slowik M; Kuliczkowski K
Hematology; 2016 Jan; 21(1):26-33. PubMed ID: 26268417
[TBL] [Abstract][Full Text] [Related]
3. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells inhibit breast cancer cell migration and invasion through secretion of tissue inhibitor of metalloproteinase-1 and -2.
Clarke MR; Imhoff FM; Baird SK
Mol Carcinog; 2015 Oct; 54(10):1214-9. PubMed ID: 24819588
[TBL] [Abstract][Full Text] [Related]
5. In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
Xu X; Yang J; Tang Y; Li J; Zhu Y; Lu H; Fei X
Int J Clin Exp Pathol; 2014; 7(10):6705-15. PubMed ID: 25400750
[TBL] [Abstract][Full Text] [Related]
6. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J
J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
[TBL] [Abstract][Full Text] [Related]
8. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.
Garcia-Gomez A; De Las Rivas J; Ocio EM; Díaz-Rodríguez E; Montero JC; Martín M; Blanco JF; Sanchez-Guijo FM; Pandiella A; San Miguel JF; Garayoa M
Oncotarget; 2014 Sep; 5(18):8284-305. PubMed ID: 25268740
[TBL] [Abstract][Full Text] [Related]
10. Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication.
Dabbah M; Lishner M; Jarchowsky-Dolberg O; Tartakover-Matalon S; Brin YS; Pasmanik-Chor M; Neumann A; Drucker L
Transl Res; 2021 Oct; 236():117-132. PubMed ID: 33887527
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
[TBL] [Abstract][Full Text] [Related]
12. SRC3 expressed in bone marrow mesenchymal stem cells promotes the development of multiple myeloma.
Jin J; Cheng S; Wang Y; Wang T; Zeng D; Li Z; Li X; Wang J
Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1258-1266. PubMed ID: 31769473
[TBL] [Abstract][Full Text] [Related]
13. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
Guo J; Zhao Y; Fei C; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
Cell Death Dis; 2018 May; 9(5):512. PubMed ID: 29724992
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow mesenchymal stromal cells with CD47 high expression via the signal transducer and activators of transcription signaling pathway preventing myocardial fibrosis.
Deng W; Chen QW; Li XS; Yuan ZM; Li GQ; Ke DZ; Wang L; Wu ZQ; Luo SL
Int J Clin Exp Pathol; 2015; 8(9):10555-64. PubMed ID: 26617765
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs.
Lozito TP; Tuan RS
J Cell Physiol; 2011 Feb; 226(2):385-96. PubMed ID: 20665704
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.
Mehdi SJ; Johnson SK; Epstein J; Zangari M; Qu P; Hoering A; van Rhee F; Schinke C; Thanendrarajan S; Barlogie B; Davies FE; Morgan GJ; Yaccoby S
Br J Haematol; 2019 Feb; 184(4):578-593. PubMed ID: 30408155
[TBL] [Abstract][Full Text] [Related]
17. Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma.
Choi H; Kim Y; Kang D; Kwon A; Kim J; Min Kim J; Park SS; Kim YJ; Min CK; Kim M
Cell Prolif; 2020 May; 53(5):e12819. PubMed ID: 32372504
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway.
Zhao P; Chen Y; Yue Z; Yuan Y; Wang X
Leuk Res; 2017 Jun; 57():20-26. PubMed ID: 28273548
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell-derived conditioned medium attenuate angiotensin II-induced aortic aneurysm growth by modulating macrophage polarization.
Zhou YZ; Cheng Z; Wu Y; Wu QY; Liao XB; Zhao Y; Li JM; Zhou XM; Fu XM
J Cell Mol Med; 2019 Dec; 23(12):8233-8245. PubMed ID: 31583844
[TBL] [Abstract][Full Text] [Related]
20. Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3.
De Becker A; Van Hummelen P; Bakkus M; Vande Broek I; De Wever J; De Waele M; Van Riet I
Haematologica; 2007 Apr; 92(4):440-9. PubMed ID: 17488654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
